Two Sigma Advisers’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,900
| Closed | -$270K | – | 2478 |
|
|
2024
Q4 | $270K | Buy |
+10,900
| New | +$270K | ﹤0.01% | 2022 |
|
|
2024
Q1 | – | Sell |
-19,400
| Closed | -$817K | – | 2536 |
|
|
2023
Q4 | $817K | Sell |
19,400
-580,900
| -97% | -$24.5M | ﹤0.01% | 1725 |
|
|
2023
Q3 | $23M | Sell |
600,300
-337,600
| -36% | -$13M | 0.06% | 279 |
|
|
2023
Q2 | $17.8M | Buy |
937,900
+97,800
| +12% | +$1.86M | 0.05% | 333 |
|
|
2023
Q1 | $13M | Buy |
840,100
+459,200
| +121% | +$7.12M | 0.03% | 456 |
|
|
2022
Q4 | $6.76M | Buy |
380,900
+39,600
| +12% | +$703K | 0.02% | 653 |
|
|
2022
Q3 | $1.9M | Sell |
341,300
-199,100
| -37% | -$1.11M | 0.01% | 1194 |
|
|
2022
Q2 | $2.11M | Sell |
540,400
-170,600
| -24% | -$665K | 0.01% | 1186 |
|
|
2022
Q1 | $3.92M | Sell |
711,000
-21,300
| -3% | -$117K | 0.01% | 917 |
|
|
2021
Q4 | $6.24M | Sell |
732,300
-276,200
| -27% | -$2.35M | 0.02% | 679 |
|
|
2021
Q3 | $8.76M | Buy |
1,008,500
+184,500
| +22% | +$1.6M | 0.02% | 564 |
|
|
2021
Q2 | $8.71M | Buy |
824,000
+243,500
| +42% | +$2.57M | 0.02% | 624 |
|
|
2021
Q1 | $9.31M | Buy |
580,500
+576,100
| +13,093% | +$9.24M | 0.03% | 599 |
|
|
2020
Q4 | $203K | Buy |
+4,400
| New | +$203K | ﹤0.01% | 2168 |
|